Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Cash from Investing Activities (2020 - 2025)

RxSight (RXST) has disclosed Cash from Investing Activities for 6 consecutive years, with -$9.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 828.33% year-over-year to -$9.6 million, compared with a TTM value of $16.9 million through Dec 2025, up 117.01%, and an annual FY2025 reading of $16.9 million, up 117.01% over the prior year.
  • Cash from Investing Activities was -$9.6 million for Q4 2025 at RxSight, down from -$9.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $43.8 million in Q2 2022 and bottomed at -$115.6 million in Q2 2024.
  • Average Cash from Investing Activities over 5 years is -$7.3 million, with a median of $2.9 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities skyrocketed 2984.82% in 2023, then tumbled 2731.29% in 2024.
  • Year by year, Cash from Investing Activities stood at -$35.3 million in 2021, then surged by 129.44% to $10.4 million in 2022, then crashed by 56.12% to $4.6 million in 2023, then plummeted by 71.09% to $1.3 million in 2024, then plummeted by 828.33% to -$9.6 million in 2025.
  • Business Quant data shows Cash from Investing Activities for RXST at -$9.6 million in Q4 2025, -$9.0 million in Q3 2025, and $14.7 million in Q2 2025.